MPG.eBooks - Search Results

1

Tisagenlecleucel for B-Cell acute lymphoblastic leukemia and diffuse large B-Cell lymphoma: Project protocol, clinical section

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Lymphoma, Large B-Cell, Diffuse / drug therapy...”

Read Now

2

Tisagenlecleucel for B-Cell acute lymphoblastic leukemia and diffuse large B-Cell lymphoma: Project protocol, clinical section

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Lymphoma, Large B-Cell, Diffuse / drug therapy...”

Read Now

3

Tisagenlecleucel for B-Cell acute lymphoblastic leukemia and diffuse large B-Cell lymphoma: Project protocol, implementation and ethics section

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Lymphoma, Large B-Cell, Diffuse / drug therapy...”

Read Now

4

Tisagenlecleucel for B-Cell acute lymphoblastic leukemia and diffuse large B-Cell lymphoma: Project protocol, implementation and ethics section

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Lymphoma, Large B-Cell, Diffuse / drug therapy...”

Read Now

5

Plerixafor for patients failing stem cell mobilization : a review of the clinical and cost-effectiveness and guidelines

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Hematopoietic Stem Cell Mobilization...”

Read Now

6

Plerixafor for patients failing stem cell mobilization : a review of the clinical and cost-effectiveness and guidelines

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Hematopoietic Stem Cell Mobilization...”

Read Now

7

Imiquimod for the treatment of basal cell or squamous cell carcinoma : a review of clinical effectiveness and cost-effectiveness

by Banerjee, Srabani, Kaunelis, David
Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Carcinoma, Squamous Cell / drug therapy...”

Read Now

8

Anaplastic lymphoma kinase inhibitors for genetically rearranged non-small cell lung cancer : a review of cost-effectiveness and guidelines

by Islam, Saadul, Argáez, Charlene
Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Carcinoma, Non-Small-Cell Lung / genetics...”

Read Now

9

Anaplastic lymphoma kinase inhibitors for genetically rearranged non-small cell lung cancer : a review of cost-effectiveness and guidelines

by Islam, Saadul, Argáez, Charlene
Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Carcinoma, Non-Small-Cell Lung / genetics...”

Read Now

10

Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Giant Cell Arteritis / drug therapy...”

Read Now

11

Clinical review report: Tocilizumab (Actemra) (Hoffmann-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Giant Cell Arteritis / drug therapy...”

Read Now

12

Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Giant Cell Arteritis / drug therapy...”

Read Now

13

Clinical review report: Tocilizumab (Actemra) (Hoffmann-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Giant Cell Arteritis / drug therapy...”

Read Now

14

Personal wireless device use for wound care consultation : a review of safety, clinical benefits, and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cell Phone / statistics & numerical data...”

Read Now

15

Bone-marrow derived stem cell injections for wound healing and tissue rejuvenation : a review of clinical effectiveness, cost-effectiveness and guidelines

by Islam, Saadul, Argáez, Charlene
Published 2017

CADTH

Subjects: “...Mesenchymal Stem Cell Transplantation...”

Read Now

16

Personal wireless device use for wound care consultation : a review of safety, clinical benefits, and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cell Phone / statistics & numerical data...”

Read Now

17

Anaplastic lymphoma kinase inhibitors for genetically rearranged non-small cell lung cancer : a review of the clinical effectiveness

by Islam, Saadul, Argáez, Charlene
Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Carcinoma, Non-Small-Cell Lung / drug therapy...”

Read Now

18

Bone-marrow derived stem cell injections for wound healing and tissue rejuvenation : a review of clinical effectiveness, cost-effectiveness and guidelines

by Islam, Saadul, Argáez, Charlene
Published 2017

CADTH

Subjects: “...Mesenchymal Stem Cell Transplantation...”

Read Now

19

Axicabtagene ciloleucel for large B-cell lymphoma: Recommendations

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Lymphoma, Large B-Cell, Diffuse / drug therapy...”

Read Now

20

Axicabtagene ciloleucel for large B-cell lymphoma: Ethics and implementation report

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Lymphoma, Large B-Cell, Diffuse / drug therapy...”

Narrow Search